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Associations between physical frailty and dementia 
incidence: a prospective study from UK Biobank
Fanny Petermann-Rocha, Donald M Lyall, Stuart R Gray, Irene Esteban-Cornejo, Terence J Quinn, Frederick K Ho*, Jill P Pell*, Carlos Celis-Morales*
Summary 
Background Dementia is associated with a high burden of dependency and disability. Physical frailty (hereafter 
referred to as frailty) is a multisystem dysregulation that has been identified as a risk factor for dementia. The aim of 
this study was to examine the association of frailty and its individual components with all-cause dementia incidence 
in a cohort of UK adults.
Methods Participants in UK Biobank with data available for dementia incidence and without any form of dementia at 
baseline were included in this prospective study. Frailty was defined using a modified version of the frailty phenotype 
based on five individual components (weight loss, tiredness, physical activity, gait speed, and grip strength), with 
participants classified as pre-frail if they fulfilled one or two criteria or frail if they fulfilled three or more. Associations 
between frailty and dementia incidence were investigated using Cox proportional hazard models adjusted for 
sociodemographic factors, lifestyle factors, and morbidity count. The population attributable fraction was also 
estimated.
Findings Of 502 535 participants in UK Biobank, 143 215 met the inclusion criteria and were included in our analyses. 
68 500 (47·8%) of the participants were pre-frail and 5565 (3·9%) were frail. During a median follow-up period of 
5·4 years, 726 individuals developed dementia. Compared with non-frail individuals, the risk of dementia incidence 
was increased for individuals with pre-frailty (hazard ratio 1·21 [95% CI 1·04–1·42]) and frailty (1·98 [1·47–2·67]) in 
the fully adjusted model. Of the five components used to define frailty, weight loss (1·31 [1·09–1·58]), 
tiredness (1·48 [1·18–1·86]), low grip strength (1·38 [1·17–1·63]), and slow gait speed (1·55 [1·22–1·96]) were 
independently associated with incident dementia. Based on population attributable fraction analyses, in the study 
sample, pre-frailty and frailty accounted for 9·9% and 8·6% of dementia cases, respectively.
Interpretation Individuals with pre-frailty and frailty were at a higher risk of dementia incidence even after adjusting 
for a wide range of confounding factors. Early detection and interventions for frailty could translate into prevention or 
delayed onset of dementia.
Funding None.
Copyright © 2020 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY-NC-ND 
license.
Introduction
Dementia is characterised by a progressive deterioration 
of cognition and the ability to perform activities of daily 
living. It is a heterogeneous syndrome associated with a 
high burden of dependency and disability and has a large 
emotional, economic, and psychological impact on 
families and society.1,2 More than 850 000 people have 
dementia in the UK.3 Globally, approximately 50 million 
individuals have dementia, and this number is estimated 
to increase to 152 million by 2050.1
Given that currently available pharmacological inter­
ventions can neither cure nor reverse dementia and offer 
little symptom relief, there is an urgent need to identify 
potential modifiable risk factors that could prevent or 
slow development of the disease. A 2020 report2 on 
dementia prevention, intervention, and care identified 
that if 12 major risk factors were modified, 40% of 
dementias could be prevented or delayed. Physical frailty 
(hereafter referred to as frailty) has also been proposed as 
a risk factor.4 Frailty is a state of high vulnerability to 
adverse health outcomes, including hospitalisations and 
deaths.5 Several studies have reported that frailty is 
associated with cognitive impairments and a higher risk 
of dementia,6–9 which might be explained by frailty and 
dementia sharing many risk factors and clinical features, 
including age, inflammation, functional impairment, 
and multimorbidity.4
The evidence from prospective cohort studies regarding 
the association between frailty and dementia has been 
conflicting. Some studies have suggested that frailty is an 
independent risk factor for dementia,6–9 whereas others 
have reported that the association between these 
two conditions is weak and could be explained mainly 
by confounding factors, including pre­existing health 
conditions.10 Discrepancies between existing studies 
could, in part, be attributable to their relatively small 
sample sizes (<10 000 participants),7–9 as well as differences 
in how frailty has been defined and measured in each 
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study. Moreover, we do not fully understand to what 
extent the association between frailty and dementia could 
be explained or moderated by pre­existing and shared risk 
factors for both conditions, and the components of the 
frailty phenotype that are most strongly associated with 
dementia remain to be elucidated. Understanding these 
features could help to tailor future interventions for 
dementia prevention. To answer these gaps in the current 
evidence, we used data from UK Biobank, a prospective 
cohort study, to investigate the association of the frailty 
phenotype, along with its individual components, with 
all­cause dementia incidence.
Methods 
Study design and participants 
UK Biobank recruited more than 500 000 participants 
(5·5% response rate), aged 37–73 years, from the general 
population between 2006 and 2010.11 Participants 
attended their closest of 22 assessment centres across 
England, Wales, and Scotland, where they completed a 
touchscreen questionnaire, had physical measurements 
taken, and provided biological samples (blood, urine, and 
saliva) at a baseline assessment visit. UK Biobank was 
approved by the North West Multi­Centre Research 
Ethics Committee (reference 11/NW/0382).
Procedures 
Record linkage to Health Episode Statistics (England and 
Wales) and the Scottish Morbidity Records (Scotland) 
was used to identify the date and cause of hospital 
admissions. Detailed information regarding the linkage 
procedure can be found online.
Incident dementia cases were ascertained from 
two sources. Hospital admission records were available 
until February, 2018, for the full UK Biobank cohort, 
whereas linkage to primary care records was available 
for 45% of the UK Biobank cohort (approximately 
230 000 participants) until May, 2017, for Scotland, 
September, 2017, for Wales, and August, 2017, for England. 
The detailed linkage procedures relating to primary care 
records are available online. The analyses of incident cases 
were restricted to the 230 000 participants with linkage to 
both primary care and hospital records, and the outcome 
was defined as either a primary care or hospital record 
of dementia, whichever occurred first. Follow­up was 
censored at the primary­care data end date for the relevant 
country, or the date of incident dementia or all­cause 
death, if this occurred earlier. Dementia was defined as 
International Classification of Diseases (10th revision) 
code F00 (dementia in Alzheimer disease), F01 (vascular 
dementia), F02 (dementia in other diseases), or F03 
(unspecified dementia).
Frailty 
The Fried frailty phenotype was used in this study 
because it is based on physical­related frailty, including 
the following five criteria: weight loss, exhaustion, physical 
activity, walking speed, and grip strength.5 However, some 
of these items were adapted to fit the data available within 
UK Biobank.12 Previous studies have suggested that 
physical capability markers, including low grip strength 
and slow walking pace, are related to a higher risk of 
dementia;13,14 however, little evidence is available regarding 
their associations as part of the frailty phenotype in the 
UK. Weight loss, tiredness or exhaustion, gait speed, and 
grip strength were derived following a similar approach 
to that of Hanlon and colleagues (appendix pp 1–4).12 
Physical activity was self­reported and collected using the 
International Physical Activity Questionnaire short form. 
Total physical activity was computed as the sum of walking, 
moderate activity, and vigorous activity, measured as 
metabolic equivalents (MET­h) per week. To derive a 
proxy for the Fried frailty phenotype, physical activity was 
categorised into age­specific and sex­specific quintiles, in 
which the lowest quintile was classified as meeting the 
physical inactivity criterion for frailty. Participants were 
Research in context
Evidence before this study
We searched Web of Science on June 1, 2020, for articles 
published in English between Jan 1, 1980, and June 1, 2020, 
using medical subject heading terms for “dementia”, 
“Alzheimer”, “neurodegenerative diseases”, “pre-frailty”, 
and “frail”. Both dementia and frailty have a substantial impact 
on individuals, families, and society. Several studies have 
reported that frailty is associated with a higher risk of dementia. 
However, the evidence from prospective cohort studies 
regarding this association has been conflicting, in part because 
of small sample sizes and differences in how frailty has been 
defined and measured in each study.
Added value of this study
This study provides a better understanding of the association 
between frailty and dementia incidence in middle-aged and 
older adults. Individuals with pre-frailty and frailty were at a 
higher risk of dementia incidence even after adjusting for a 
wide range of confounder factors, including multimorbidity. 
We also identified that weight loss, low grip strength, tiredness, 
and slow gait speed were the main components of the frailty 
phenotype that were associated with dementia. These findings 
highlight that public health strategies aiming to improve 
physical capabilities in middle-aged and older adults could 
reduce the burden of both frailty and dementia. 
Implications of all the available evidence
Given the increased risk of dementia incidence in people with 
frailty, early assessment and interventions from middle age 
should be implemented in the general population to prevent 
frailty, and consequently, reduce the risk of dementia.
For more on the linkage 
procedure for hospital 
admissions see http://content.
digital.nhs.uk/services
For more on linkage procedures 
relating to primary care records 
see http://content.digital.nhs.uk/
services
See Online for appendix
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classified as frail if they fulfilled three or more of the 
five criteria, pre­frail if they fulfilled one or two criteria, 
and robust (non­frail) if they did not fulfil any criteria at 
baseline. The three groups were mutually exclusive.
Covariates 
Age was calculated from dates of birth and based on the 
date of baseline assessment. Area­based socioeconomic 
status (deprivation) was derived from the postcode of 
residence using the Townsend score.15 Ethnicity was self­
reported and categorised into white, south Asian, 
black, Chinese, or mixed ethnic background. Education 
attainment was self­reported and coded as an ordinal 
variable. Participants were asked which of the following 
qualifications they held: CSEs, O­levels, A­levels, college 
or university degree, NVQ, HND, NHC, or equivalent, 
other professional qualification, or none of these. 
Self­reported smoking status was categorised as never, 
former, or current smoker. Total time spent in dis­
cretionary sedentary behaviours was derived from the 
sum of self­reported time spent driving, using a computer, 
and watching television during leisure time. Body­mass 
index (BMI) was calculated as weight divided by the 
square of height (kg/m²) and WHO criteria were applied 
to define weight categories.16 Hours of sleep were self­
reported and categorised as normal (7–9 h) and long or 
short sleep (>9 h or <7 h, respectively). Leisure or social 
activities, frequency of alcohol intake, and frequency of 
friend and family visits were self­reported at baseline via 
touchscreen questionnaire. Red meat, processed meat 
and fruit and vegetable intake were also collected through 
the touch­screen questionnaire at baseline. Prevalent 
morbidity was ascertained during a nurse­led interview at 
baseline. We calculated morbidity count (coded as 1, 2, 3, 
4, or ≥5) based on 43 long­term conditions developed 
initially for a large epidemiological study in Scotland and 
subsequently adapted for UK Biobank.17 Total cholesterol 
and glycated haemo globin A1c (HbA1c) were analysed from 
serum and packed red blood cell samples. Systolic and 
diastolic blood pressure were derived from the mean of 
two readings recorded in the left arm. Reaction­time tests 
(timed tests of symbol matching) were completed through 
a touchscreen tool (Snap). Further details of these 
measurements can be found in the appendix (pp 3–4). 
Only partici pants with complete data available for the 
five components of frailty and covariates were included in 
analyses.
Statistical analysis 
Descriptive characteristics are presented as means with 
SDs for quantitative variables that were normally 
distributed, and as medians with IQRs for those that 
were non­normally distributed. Categorical variables are 
presented as frequencies and percentages. STATA 16 
statistical software was used for all analyses.
Associations between frailty and dementia incidence 
were investigated using Cox proportional hazard models. 
Individuals classified as non­frail were used as the 
reference group. The results are reported as hazard 
ratios (HRs) with 95% CIs. In addition, a sensitivity 
analysis was done a posteriori to evaluate associations 
between frailty and three subtypes of dementia inci­
dence: vascular dementia, non­specific dementia, and 
Alzheimer’s diseases (including early, late, and other non­
specified Alzheimer’s disease). Associations between the 
five components of the frailty phenotype and dementia 
incidence were investigated using the aforementioned 
analyses. The normal range for each component was 
used as the reference group. Additionally, non­linear 
associations between the number of individual com­
ponents of frailty and the outcome were formally 
tested using penalised cubic splines fitted in the Cox 
proportional hazard models.
To avoid a possible reverse causality (ie, a causal 
relationship operating in the opposite way to that which 
truly occurs),18 all analyses were done using a 2­year 
landmark analysis, excluding participants who experienced 
events within the first 2 years of follow­up. Participants 
with all­cause dementia at baseline were also excluded 
from the follow­up analyses. The proportional hazard 
assumptions were checked using Schoenfeld residuals.
We ran three models for each outcome, including an 
increasing number of covariates: model 1 (minimally 
adjusted) included sociodemographic covariates (age, 
sex, deprivation, ethnicity, and education); model 2 
additionally included lifestyle factors (leisure or social 
activities, frequency of friend and family visits, smoking, 
sleep duration, total discretionary sedentary time, alcohol 
Figure 1: Participant selection
502 535 participants in UK Biobank
 
228 640 participants with data available for 
dementia incidence outcome 
273 895 excluded
30 withdrew during follow-up
273 865 data not available for dementia 
incidence 
143 259 participants with all relevant data 
available
85 351 excluded
51 555 data not available for frailty
34 226 data missing for one or more 
covariates 
143 215 participants included in analyses 
44 excluded due to having dementia
at baseline 
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Whole population Non-frail Pre-frail Frail
Total 143 215 (100·0%) 69 150 (48·3%) 68 500 (47·8%) 5565 (3·9%)
Sociodemographic factors
Age at baseline, years 58·0 (50·0–63·0) 57·0 (50·0–63·0) 58·0 (51·0–63·0) 59·0 (53·0–64·0)
Sex
Female 77 320 (54·0%) 35 216 (50·9%) 38 564 (56·3%) 3540 (63·6%)
Male 65 895 (46·0%) 33 934 (49·1%) 29 936 (43·7%) 2025 (36·4%)
Deprivation
Lower 49 250 (34·4%) 25 564 (37·0%) 22 478 (32·8%) 1208 (21·7%)
Middle 49 781 (34·8%) 24 627 (35·6%) 23 494 (34·3%) 1660 (29·8%)
Higher 44 184 (30·9%) 18 959 (27·4%) 22 528 (32·9%) 2697 (48·5%)
Ethnicity
White 137 759 (96·2%) 67 341 (97·4%) 65 425 (95·5%) 4993 (89·7%)
Mixed 1595 (1·1%) 593 (0·9%) 858 (1·3%) 144 (2·6%)
South Asian 2378 (1·7%) 614 (0·9%) 1442 (2·1%) 322 (5·8%)
Black 1167 (0·8%) 472 (0·7%) 607 (0·9%) 88 (1·6%)
Chinese 316 (0·2%) 130 (0·2%) 168 (0·2%) 18 (0·3%)
Education
CSEs 7617 (5·3%) 3682 (5·3%) 3638 (5·3%) 297 (5·3%)
O-levels 31 238 (21·8%) 15 074 (21·8%) 15 012 (21·9%) 1152 (20·7%)
A-levels 15 970 (11·2%) 7746 (11·2%) 7690 (11·2%) 534 (9·6%)
College or university degree 47 936 (33·5%) 24 865 (36·0%) 21 837 (31·9%) 1234 (22·2%)
NVQ, HND, HNC, or equivalent 9800 (6·8%) 4728 (6·8%) 4666 (6·8%) 406 (7·3%)
Other professional qualification 7612 (5·3%) 3611 (5·2%) 3740 (5·5%) 261 (4·7%)
None of the above 23 042 (16·1%) 9444 (13·7%) 11 917 (17·4%) 1681 (30·2%)
Obesity-related markers
Bodyweight, kg 77·6 (15·4) 76·3 (14·7) 78·4 (15·8) 82·7 (18·0)
Height, m 1·69 (0·09) 1·70 (0·09) 1·68 (0·09) 1·65 (0·09)
BMI, kg/m² 27·2 (4·5) 26·4 (4·01) 27·8 (4·7) 30·4 (6·0)
BMI category, kg/m²
<18·5 (underweight) 700 (0·5%) 323 (0·5%) 342 (0·5%) 35 (0·6%)
18·5–24·9 (normal weight) 47 959 (33·5%) 27 197 (39·3%) 19 777 (28·9%) 985 (17·7%)
25·0–29·9 (overweight) 61 985 (43·3%) 30 454 (44·0%) 29 704 (43·4%) 1827 (32·8%)
≥30·0 (obese) 32 571 (22·7%) 11 176 (16·2%) 18 677 (27·3%) 2718 (48·8%)
Fitness and lifestyle








Sedentary behaviour, h per day 5·0 (4·0–6·0) 5·0 (3·0–6·0) 5·0 (4·0–6·0) 5·0 (4·0–7·0)
Alcohol intake frequency
Daily or almost daily 29 872 (20·9%) 15 986 (23·1%) 13 173 (19·2%) 713 (12·8%)
3–4 times a week 34 635 (24·2%) 18 418 (26·6%) 15 519 (22·7%) 698 (12·5%)
Once or twice a week 37 702 (26·3%) 18 269 (26·4%) 18 143 (26·5%) 1290 (23·2%)
1–3 times a month 15 645 (10·9%) 6956 (10·1%) 7957 (11·6%) 732 (13·2%)
Special occasions only 15 076 (10·5%) 5816 (8·4%) 8139 (11·9%) 1121 (20·1%)
Never 10 285 (7·2%) 3705 (5·4%) 5569 (8·1%) 1011 (18·2%)
Red meat intake, portions per week 1·5 (1·5–2·5) 2·0 (1·5–2·5) 2·0 (1·5–2·5) 1·5 (1·5–2·5)
Processed meat intake, portions per week 2·0 (1·0–3·0) 2·0 (1·0–3·0) 2·0 (1·0–3·0) 2·0 (1·0–3·0)
Fruit and vegetable intake, g per day 337·5 (193·5) 341·2 (189·5) 334·6 (195·8) 327·7 (213·7)
Smoking status
Never 78 961 (55·1%) 38 956 (56·3%) 37 251 (54·4%) 2754 (49·5%)
Previous 50 323 (35·1%) 24 108 (34·9%) 24 275 (35·4%) 1940 (34·9%)
Current 13 931 (9·7%) 6086 (8·8%) 6974 (10·2%) 871 (15·7%) 
(Table 1 continues on next page)
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intake, and consumption of red meat, processed meat, 
and fruit and vegetables) and BMI; and model 3 
additionally included morbidity count (based on 
43 diseases and coded as 1, 2, 3, 4, or ≥5; appendix pp 3–4), 
vascular factors (blood pressure, total cholesterol, and 
HbA1c), and reaction time (log­transformed to avoid the 
effect of outliers) at baseline. Model 4 was run only 
for the analyses of the five individual components 
of frailty and included mutual adjustment for the other 
four components of frailty. Percentage risk difference 
across models was estimated using the formula: 
(HRmodel 2 – HRmodel 1)/(HRmodel 1 –1) × 100%.
The cumulative crude hazard rate of incident dementia 
and the frailty phenotype by age was estimated using the 
Nelson­Aalen estimator. The rate advancement period 
was also estimated, defined as the number of additional 
chronologic years that would be required to yield the 
equivalent risk rate for dementia incidence among the 
frailty phenotype and its individual components. For its 
estimation, the logarithm HR for incidence of the frailty 
phenotype and its individual components was divided by 
the corresponding incidence associated with each yearly 
increase in age—eg, log(HRfrail) divided by log(HRage).19 
Additionally, the population attributable fraction was 
estimated to calculate the proportion of dementia incident 
cases that were attributable to both the frailty phenotype 
(pre­frail and frail) and its individual components, 
assuming causality. This population attributable fraction 
was estimated on the basis of the adjusted HR derived 
from model 3 and prevalence in the sample.
Finally, to investigate whether the associations between 
frailty and incident dementia differed by subgroups, the 
models were run stratified by sex, age category (<60 and 
≥60 years), deprivation index (below and above median), 
level of adiposity (normal and overweight or obese), sleep 
pattern (normal and long or short sleep duration), 
morbidity count (none and one or more) and smoking 
status (never and previous or current). A further 
sensitivity analysis was done in which age was stratified 
with 65 years as the cutoff.
Whole population Non-frail Pre-frail Frail
(Continued from previous page)
Sleep time
Normal 106 894 (74·6%) 53 859 (77·9%) 49 708 (72·6%) 3327 (59·8%)
Long or short 35 947 (25·1%) 15 184 (21·9%) 18 565 (27·1%) 2198 (39·5%)
Do not know or prefer not to answer 374 (0·3%) 107 (0·2%) 227 (0·3%) 40 (0·7%)
Social activities
Sports club or gym 34 635 (24·2%) 27 109 (39·2%) 19 421 (28·4%) 873 (15·7%)
Pub or social club 37 702 (26·3%) 12 235 (17·7%) 13 263 (19·4%) 1116 (20·1%)
Religious group 15 645 (10·9%) 5022 (7·3%) 6721 (9·8%) 777 (14·0%)
Adult education class 15 076 (10·5%) 1839 (2·7%) 2094 (3·1%) 178 (3·2%)
Another group activity 10 285 (7·2%) 5831 (8·4%) 6461 (9·4%) 473 (8·5%)
None of the above 29 872 (20·9%) 17 114 (24·7%) 20 540 (30·0%) 2148 (38·6%)
Frequency of friend or family visits
Almost daily 17 384 (12·1%) 7942 (11·5%) 8577 (12·5%) 865 (15·5%)
2–4 times a week 45 111 (31·5%) 22 229 (32·1%) 21 210 (31·0%) 1672 (30·0%)
About once a week 50 862 (35·5%) 25 048 (36·2%) 24 025 (35·1%) 1789 (32·1%)
About once a month 18 387 (12·8%) 8853 (12·8%) 8905 (13·0%) 629 (11·3%)
Once every few months 8929 (6·2%) 4119 (6·0%) 4411 (6·4%) 399 (7·2%)
Never or almost never 1869 (1·3%) 724 (1·0%) 998 (1·5%) 147 (2·6%)
No friends or family outside household 259 (0·2%) 73 (0·1%) 154 (0·2%) 32 (0·6%)
Do not know or prefer not to answer 414 (0·3%) 162 (0·2%) 220 (0·3%) 32 (0·6%)
Health status
Multimorbidity
None 50 278 (35·1%) 28 473 (41·2%) 21 117 (30·8%) 688 (12·4%)
One or more conditions 92 937 (64·9%) 40 677 (58·8%) 47 383 (69·2%) 4877 (87·6%)
Reaction time, ms 721·6 (119·6) 714·1 (112·0) 726·9 (123·5) 750·4 (151·7)
Total cholesterol, mmol/L 5·7 (1·1) 5·8 (1·1) 5·7 (1·2) 5·4 (1·2)
HbA1c, mmol/L 35·9 (6·5) 35·3 (5·3) 36·3 (7·0) 39·3 (10·7)
Systolic blood pressure, mm Hg 138·0 (18·6) 138·3 (18·7) 137·8 (18·5) 136·7 (18·6)
Diastolic blood pressure, mm Hg 82·3 (10·1) 82·4 (10·1) 82·2 (10·1) 81·6 (10·3)
Data are n (%), median (IQR), or mean (SD). Percentages might not add to 100% due to rounding. BMI=body-mass index. MET-h=metabolic equivalents. HbA1c=glycated 
haemoglobin A1c.
Table 1: Baseline characteristics by frailty category
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Role of the funding source
There was no funding source for this study. FP­R, FKH, 
JPP, and CC­M had full access to all the data in the study 
and had final responsibility for the decision to submit for 
publication.
Results
Of 502 535 participants in UK Biobank, 228 640 had data 
available for dementia incidence, of whom 143 259 had 
data available for the frailty components and covariates. 
44 of these participants had dementia at baseline and 
were excluded. Therefore, this prospective study included 
143 215 participants (figure 1). After excluding the 2­year 
landmark period, the median follow­up period was 
5·4 years (IQR 4·8–6·3) for dementia incidence. Over 
the follow­up period, 726 (0·5%) of the participants 
developed dementia.
Cohort characteristics by overall frailty phenotype are 
presented in table 1; characteristics by individual frailty 
component are presented in the appendix (pp 5–7). 
69 150 (48·3%) of 143 215 participants were in the normal 
range for all five components; 51 047 (35·6%) had at least 
one frailty component, and 102 (0·1%) had all 
components. Of those who had one or more components, 
68 500 (47·8%) were classified as pre­frail and 
5565 (3·9%) as frail. Compared with non­frail people, 
those with frailty were more likely to be older, more 
deprived, more likely to be south Asian, female, obese, 
and a current smoker, and to report that they never drank 
alcohol. They were less likely to have a formal education, 
to take part in social activities, and to have visits from 
friends or family outside the household. They also had 
lower levels of physical activity and slower reaction times 
than non­frail individuals. Lastly, individuals with 
pre­frailty and frailty were more likely to have long or 
short sleep, higher levels of HbA1c, and one or more 
morbidities than non­frail individuals (table 1).
Associations between the frailty phenotype and 
dementia incidence are shown in table 2. In the 
minimally adjusted model, individuals with pre­frailty 
(HR 1·20 [95% CI 1·03–1·40]) and frailty (2·08 
[1·57–2·76]) had an increased risk of incident dementia 
compared with non­frail individuals. The magnitude of 
these associations was slightly higher if the model was 
further adjusted for lifestyle factors and BMI (model 2; 
20·0% higher risk for pre­frailty and 11·1% higher risk 
for frailty). However, the associations were attenuated 
after adjusting for morbidity count and health­related 
factors (model 3; 1·21 [1·04–1·42] for pre­frailty and 1·98 
[1·47–2·67] for frailty). Individuals with frailty had a 
steeper crude cumulative incidence of dementia 
compared with non­frail individuals (appendix p 9). 
When the analyses were stratified by the subtypes of 
dementia (vascular dementia, non­specific dementia, 
and Alzheimer’s disease), pre­frailty and frailty were 
Pre-frail (n=68 500) Frail (n=5565)
HR (95% CI) p value Risk difference 
from model 1, %
HR (95% CI) p value Risk difference 
from model 1, %
Model 1 1·20 (1·03–1·40) 0·019 ·· 2·08 (1·57–2·76) <0·0001 ··
Model 2 1·24 (1·06–1·45) 0·0060 20·0% 2·20 (1·64–2·94) <0·0001 11·1%
Model 3 1·21 (1·04–1·42) 0·016 5·0% 1·98 (1·47–2·67) <0·0001 –9·3%
 Total number of participants was 143 103; 726 events (incident dementia) occurred. Dementia incidence was 
estimated using primary care data. Non-frail people were used as the reference group. All analyses were done using a 
2-year landmark analysis, excluding participants who experienced events within the first 2 years of follow-up (n=112). 
Model 1 included sociodemographic covariates (age, sex, deprivation, ethnicity, and education); model 2 additionally 
included lifestyle factors (leisure or social activities, frequency of friend and family visits, smoking, sleep duration, total 
discretionary sedentary time, alcohol intake, and consumption of red meat, processed meat, and fruit and vegetables) 
and body-mass index; model 3 additionally included morbidity count, vascular factors (blood pressure, total 
cholesterol, and glycated haemoglobin A1c), and reaction time at baseline.
Table 2: Associations between frailty and dementia incidence 
HR (95% CI) p value
Weight loss 
Model 1 1·36 (1·13–1·64) 0·0010
Model 2 1·34 (1·11–1·61) 0·0020
Model 3 1·31 (1·09–1·58) 0·0040
Model 4 1·31 (1·09–1·58) 0·0050
Tiredness or lack of energy 
Model 1 1·61 (1·30–2·01) <0·0001
Model 2 1·60 (1·28–1·99) <0·0001
Model 3 1·48 (1·18–1·86) 0·0010
Model 4 1·39 (1·10–1·74) 0·0050
Low physical activity levels 
Model 1 0·95 (0·79–1·14) 0·56
Model 2 0·98 (0·82–1·18) 0·84
Model 3 0·97 (0·80–1·16) 0·73
Model 4 0·93 (0·78–1·12) 0·48
Low grip strength 
Model 1 1·39 (1·18–1·63) <0·0001
Model 2 1·44 (1·22–1·69) <0·0001
Model 3 1·38 (1·17–1·63) <0·0001
Model 4 1·34 (1·13–1·58) 0·0010
Slow gait speed 
Model 1 1·62 (1·30–2·03) <0·0001
Model 2 1·72 (1·36–2·16) <0·0001
Model 3 1·55 (1·22–1·96) <0·0001
Model 4 1·41 (1·10–1·79) 0·0060
Total number of participants was 143 103; 726 events (incident dementia) 
occurred. Participants with a normal range for each component was used as the 
reference group. All analyses were done using a 2-year landmark analysis, 
excluding participants who experienced events within the first 2 years of follow-up 
(n=112). Model 1 included sociodemographic covariates (age, sex, deprivation, 
ethnicity, and education); model 2 additionally included lifestyle factors (leisure or 
social activities, frequency of friend and family visits, smoking, sleep duration, 
total discretionary sedentary time, alcohol intake, and consumption of red meat, 
processed meat, and fruit and vegetables) and body-mass index; model 3 
additionally included morbidity count, vascular factors (blood pressure, total 
cholesterol, and glycated haemoglobin A1c), and reaction time at baseline; model 4 
additionally included the five individual components when these were not the 
exposure (sensitivity analysis).
Table 3: Individual components of frailty and their association with 
all-cause dementia incidence
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asso ciated with vascular dementia (model 3; 1·70 
[1·10–2·62] for pre­frailty, 3·00 [1·54–5·82] for frailty) 
but not non­specific dementia or Alzheimer’s disease 
(appendix p 10).
Of the five components used to define frailty, weight 
loss (HR 1·31 [95% CI 1·09–1·58]), tiredness (1·48 
[1·18–1·86]), low grip strength (1·38 [1·17–1·63]), and 
slow gait speed (1·55 [1·22–1·96]) were independently 
associated with the risk of dementia incidence (model 3; 
table 3). When the analyses were mutually adjusted by 
components of frailty (model 4), the associations were 
attenuated but remained significant. Although we found 
no evidence of a non­linear association between the 
number of frailty components and logarithm risk of 
dementia incidence, the risk for dementia incidence 
increased markedly for individuals who had two to 
five components of the frailty phenotype. The hazard for 
dementia incidence was two­times higher for individuals 
with five components of the frailty criteria compared 
with those with none (figure 2, lower panel).
When the analyses were stratified by subgroup, no 
significant interactions were identified for pre­frailty and 
dementia incidence (figure 3). However, a significant 
interaction between frailty and age was observed 
(p=0·0050); individuals with frailty aged younger than 
60 years had an increased risk of dementia incidence 
compared with those aged 60 years and older (figure 3). 
When the analyses were performed using a cutoff of 
65 years, the associations were attenuated, but a similar 
pattern of association was observed (appendix p 11).
Based on population attributable fraction analyses, 
pre­frailty accounted for 9·90% (95% CI 1·61–17·5) of 
dementia cases and frailty accounted for 8·55% 
(3·83–13·00; table 4). Among the five individual com­
ponents, low grip strength had the highest population 
attributable fraction compared with the other individual 
components, accounting for 8·84% (3·99–13·40) of 
incident dementia cases. Based on rate advancement 
period analyses, individuals with frailty are likely to 
experience dementia 3·58 years (95% CI 2·33–4·74) 
earlier than non­frail individuals. Among the frailty 
components, individuals with slow gait speed have the 
largest rate advancement (2·3 years [1·20–3·25] before 
those with normal gait speed).
Discussion 
In this study, using data from 143 215 participants from 
UK Biobank, we identified that individuals with pre­frailty 
and frailty were at a higher risk of dementia incidence 
compared with non­frail individuals, even after adjusting 
for a wide range of confounding factors, including 
sociodemographic factors, lifestyle factors, adiposity, 
morbidity count, and health­related markers. Furthermore, 
pre­frailty and frailty accounted for 9·9% and 8·6% of 
dementia cases in the study sample, respectively. Pre­
frailty accounts for a greater proportion of dementia cases 
than frailty because of the higher prevalence of pre­frailty 
compared with frailty in UK Biobank. Participants with 
pre­frailty could also be at a milder stage of dementia,20 
which warrants further investigation. Considering that 
frailty might be a reversible syndrome and that dementia 
is not part of the natural ageing process, the burden of 
dementia­related morbidity attributable to frailty might 
be modifiable by delaying its onset. Therefore, public 
strategies aiming to improve physical capabilities, 
especially those related to muscle strength in middle­aged 
and older adults, might contribute to reducing the burden 
of frailty and, as a consequence, reduce the dementia risk 
attributable to frailty.
Figure 2: Non-linear associations between number of individual components 
of the frailty phenotype and dementia incidence
Data are presented as adjusted HR with the 95% CI shown as shading. Non-frail 
people were used as the reference group. Model 1 included sociodemographic 
covariates (age, sex, deprivation, ethnicity, and education); model 2 additionally 
included lifestyle factors (leisure or social activities, frequency of friend and 
family visits, smoking, sleep duration, total discretionary sedentary time, alcohol 
intake, and consumption of red meat, processed meat, and fruit and vegetables) 
and body-mass index; model 3 additionally included morbidity count, vascular 
factors (blood pressure, total cholesterol, and glycated haemoglobin A1c), 
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Figure 3: Associations between all-cause dementia incidence and pre-frailty (A) and frailty (B) by subgroup
Non-frail people were used as the reference group for each subgroup. All analyses were done using a 2-year landmark analysis, excluding participants who 
experienced events within the first 2 years of follow-up (n=112). Analyses were adjusted by age, sex, deprivation, ethnicity, education, morbidity count, blood 
pressure, total cholesterol, glycated haemoglobin A1c, reaction time, body-mass index, leisure or social activities, frequency of friend or family visits, smoking, total 
discretionary sedentary time, sleep duration, and consumption of alcohol, red meat, processed meat, and fruit and vegetables, when these were not the subgroups 
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The associations between dementia and frailty have 
been previously reported using both multidimensional 
models (eg, the frailty index),9 and, as in our study, 
using the frailty phenotype. However, most studies 
have used smaller sample sizes and had older 
populations, in which the risk of dementia could be 
higher due to the age of the population rather than the 
frailty status. For instance, Gray and colleagues,8 who 
studied 2619 adults older than 65 years, showed 
that frailty, but not pre­frailty, was associated with 
a 1·78­times increased risk of incident dementia and a 
4·46­times risk of non­Alzheimer dementia, compared 
with non­frail individuals. These asso ciations were 
attenuated when the analyses were further adjusted 
for BMI and health status, and remained signifi cant 
only for non­Alzheimer’s dementia in the maximally 
adjusted model.8 Similarly, a study of 2581 Italian adults 
aged 65–84 years identified that, using the frailty 
phenotype, individuals with frailty were associated with 
a 1·85­times risk of overall incident dementia and 
2·68­times risk of vascular dementia.7 In the UK, 
a dose­response relationship between a frailty index 
(multidimensional model) and dementia was identified 
in 8722 older adults from the English Longitudinal 
Study of Ageing (ELSA).9 Findings from ELSA were 
similar to those in our study; individuals who were 
pre­frail had a 1·60­times increased risk of dementia 
and individuals who were frail had a 1·60­times 
increased risk, compared with non­frail individuals. 
However, in ELSA, dementia cases were self­reported 
and not clinically diagnosed.9
Frailty and dementia are strongly related and share 
similar common risk factors, such as sociodemographic 
factors (eg, age and deprivation), morbidities, and lifestyle 
factors.21 Of note, in our study, individuals with pre­frailty 
and frailty with lower levels of deprivation had a higher 
risk of dementia compared with their counterparts with 
greater deprivation. This result is discordant with the 
findings of ELSA, in which individuals who were more 
deprived (in the lowest quintile) had a 1·68­times increased 
risk of dementia compared with the least deprived (highest 
quintile).22 Individuals with pre­frailty and frailty who are 
more deprived might have higher resilience than those 
who are less deprived, allowing for better adaptation or 
managing of stress situations, trauma, or inequalities.23 
More studies are needed to evaluate the role of deprivation 
in frailty and dementia. Previous studies have identified 
that a dysregulation through multiple biological systems 
is a potential cause for both frailty and dementia.24 
This dysregulation might be caused by the presence 
of comorbidities, which contribute to both frailty and 
dementia. However, in our study, an association between 
frailty and dementia outcomes remained after adjusting 
for morbidity count, suggesting that the association is not 
merely the result of confounders.
Consistent with our results, low grip strength and slow 
gait speed or balance and gait impairment have been 
attributed to a worse cognitive condition among people 
with frailty.21 Previous studies have shown that both 
gait speed and grip strength could be independent early 
markers of dementia,13 and that these two components of 
frailty are the most strongly associated with cognitive 
impairment related to frailty.14 Some of the potential 
mechanisms implicated are neurodegeneration (which 
contributes to both dementia and the decrease of physical 
capability markers); inflammation, described as an incre­
ment of pro­inflammatory markers; vascular mechanisms, 
related to microdamage mainly in the frontal­subcortical 
region; or a shared brain region (ie, gait speed and 
cognition could rely on a similar region).13 Of note, in our 
study, the strongest association was between frailty and 
vascular dementia, which highlights that stroke, cerebro­
vascular disease, or both, could be one of the mechanisms.25 
Additionally, frailty is associated with a reduction in the 
leisure and social activities that contribute to the wellbeing 
and life satisfaction of individuals.26 This lower social 
interaction could increase the risk of dementia, as has 
been previously shown.27
The assessment and surveillance of frailty could help 
to decrease its associated adverse health outcomes, 
including dementia. Of note, according to our rate 
advancement period analyses, individuals with frailty 
could experience dementia approximately 3 years earlier 
than non­frail individuals. However, frailty is not 
routinely assessed in clinical practice. A multicentre 
study of 388 clinicians (mainly medical doctors) from 
44 countries showed that only 52·8% routinely assessed 
frailty in daily practice.28 The assessment rate was higher 
among geriatricians than other medical specialties,28 
consistent with frailty being normally associated with 
ageing. However, its development begins earlier in life, 
and an association between frailty and cognition has 
been recognised independent of age.29 Although in our 
study, only older individuals with pre­frailty had a higher 
risk of dementia compared with non­frail individuals, 
individuals with frailty younger than 60 years had 
Population attributable fraction, % 
(95% CI)
Rate advancement period, years 
(95% CI)
Weight loss 4·54% (1·08 to 7·88) 1·42 (0·50 to 2·21) 
Tiredness 4·27% (1·50 to 6·96) 2·06 (0·95 to 3·00) 
Low physical activity –0·65% (–4·36 to 2·93) –0·16 (–1·28 to 0·72) 
Low grip strength 8·84% (3·99 to 13·40) 1·77 (0·95 to 2·46) 
Slow gait speed 4·48% (1·67 to 7·21) 2·30 (1·20 to 3·25) 
Pre-frailty 9·90% (1·61 to 17·50) 1·00 (0·24 to 1·69)
Frailty 8·55% (3·83 to 13·00) 3·58 (2·33 to 4·74) 
All analyses were done using a 2-year landmark analysis, excluding participants who experienced events within the first 
2 years of follow-up (n=112). Analyses were adjusted by age, sex, deprivation, ethnicity, education, morbidity count, 
blood pressure, total cholesterol, glycated haemoglobin A1c, reaction time, body-mass index, leisure or social activities, 
frequency of friend or family visits, smoking, total discretionary sedentary time, sleep duration, and consumption of 
alcohol, red meat, processed meat, and fruit and vegetables (model 3). 
Table 4: Population attributable fraction and rate advancement periods of incident dementia attributable 
to frailty and its components
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a 5·78­times increased risk of incident dementia com­
pared with a 1·76­times increased risk among those aged 
60 years and older. This finding highlights the association 
between frailty and dementia as modified by age, and 
also shows that the onset of frailty could start much 
earlier in life. Therefore, our study provides novel 
evidence regarding the association between frailty and 
dementia incidence, not only in older adults as has been 
previously shown, but also in middle­aged adults. These 
findings are supported by a study by Gil­Salcedo and 
colleagues,30 which showed that a healthier lifestyle 
(eg, not smoking, moderate alcohol consumption, 
2·5 hours per week of physical activity) during the 
middle age (at 50 years) of participants from the UK 
Whitehall II cohort was associated with a lower risk of 
frailty during 20 years of follow­up. In this context, 
considering that previous studies have shown that frailty 
might be reversed with exercise interventions in some 
older adults,31 early assess ment and interventions from 
middle age should be implemented among the general 
population to prevent frailty, and consequently, reduce 
the risk of dementia. However, further studies in the 
field are still needed.
UK Biobank is a large, prospective, general population 
cohort with data available on a wide range of potential 
confounders and health outcomes. As a result, our 
analyses could be adjusted for multiple confounders and 
stratified by different subgroups. However, UK Biobank 
participants are not representative of the UK population 
because they are more likely to have healthier behaviours 
than the general UK population; 32 therefore, the summary 
statistics should not be generalised even though the 
effect sizes estimated from UK Biobank were generally 
consistent with those from population­representative 
cohorts. In addition, the frailty phenotype was created 
using similar but not identical variables to those suggested 
by Fried and colleagues,5 and four of the five variables were 
self­reported. Furthermore, the frailty phenotype was 
derived from baseline UK Biobank data, and these data 
could have changed over time. Our analysis might have 
underestimated the associations because frailty might not 
develop until older age for some people. Although we were 
able to adjust our model for one cognitive test, UK Biobank 
does not have other cognitive measurements, such as the 
Mini­Mental State Examination or the Instrumental 
Activities of Daily Living. Therefore, residual confounding 
might have occurred due to baseline cognitive ability, 
which could overestimate the association. Similarly, our 
study did not adjust for apolipoprotein E polymorphism, 
a major risk factor for dementia. However, a previous 
study found no association between apolipoprotein E 
polymorphism and frailty.33 Additionally, we note that our 
sample might not have sufficient power for dementia 
subtype analysis. Finally, although we performed a 2­year 
landmark analysis excluding participants who experienced 
events in the first 2 years after recruitment, reverse 
causality is possible in any observational study.
In conclusion, frailty (both the pre­frail and frail status) 
was associated with a higher risk of dementia incidence. 
Furthermore, among the five components used to define 
frailty in this study, slow gait speed and low grip strength 
made the largest contributions to dementia incidence. 
Considering that frailty is a modifiable syndrome in 
middle age, its early detection and treatment might 
represent a target for prevention or delayed onset of 
neuro degenerative diseases, including dementia.
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